Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion — RxCUI 1494174
RxNorm drug concept · Semantic clinical drug
RxCUI 1494174
Semantic clinical drug · SCD
● Current RxNorm concept 5 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1494174
Official nameSulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assulfacetamide sodium 9.8 % / sulfur 4.8 % Topical Lotion
FDA products mapped5
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sulfacetamide Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's an antibiotic drop that targets bacterial infections on the surface of your eye. The most common reason it's prescribed is conjunctivitis — what most people call pink eye — ca...
- What is this eye drop actually treating?
- At the start of treatment, you'll use them quite frequently — typically every two to three hours. As your eye starts to get better, your doctor will usually have you space the dose...
- How often do I need to put the drops in?
🕸️ Concept Web — How Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion
RxCUI 1494174 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Sulfacetamide
10169IN -
Sulfur
10223IN -
Sulfacetamide / sulfur
690740MIN -
Sulfacetamide sodium
82101PIN
-
Sulfacetamide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Plexion
352897BN
-
Plexion
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sulfacetamide / sulfur Topical Lotion
377818SCDF -
Sulfacetamide sodium / sulfur Topical Lotion
2649118SCDFP -
Sulfacetamide / sulfur Topical Product
1162333SCDG -
Sulfacetamide sodium / sulfur Topical Product
2662055SCDGP -
Sulfacetamide / sulfur Topical Lotion [Plexion]
543659SBDF -
Sulfacetamide sodium / sulfur Topical Lotion [Plexion]
2656786SBDFP -
Plexion Topical Product
1181807SBDG -
Topical Lotion
316983DF - +1 more in this family
-
Sulfacetamide / sulfur Topical Lotion
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sulfacetamide sodium 98 MG/ML
1494167SCDC -
Sulfur 48 MG/ML
1494168SCDC -
Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion [Plexion]
1494824SBD -
Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML [Plexion]
1494823SBDC
-
Sulfacetamide sodium 98 MG/ML
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sulfacetamide sodium 98 MG/ML
SCDC · 1494167 -
Sulfur 48 MG/ML
SCDC · 1494168 -
Sulfacetamide / sulfur Topical Lotion
SCDF · 377818 -
Sulfacetamide sodium / sulfur Topical Lotion
SCDFP · 2649118 -
Sulfacetamide / sulfur Topical Product
SCDG · 1162333 -
Sulfacetamide sodium / sulfur Topical Product
SCDGP · 2662055
Brand-Name Concepts
-
Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML Topical Lotion [Plexion]
SBD · 1494824 -
Sulfacetamide sodium 98 MG/ML / sulfur 48 MG/ML [Plexion]
SBDC · 1494823 -
Sulfacetamide / sulfur Topical Lotion [Plexion]
SBDF · 543659 -
Sulfacetamide sodium / sulfur Topical Lotion [Plexion]
SBDFP · 2656786 -
Plexion Topical Product
SBDG · 1181807 -
Plexion
BN · 352897
📦 FDA Products & Package NDCs
5 products · 5 package NDCs
5 package NDCs map to RxCUI 1494174 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 24470-0944-02 | 57 g in 1 BOTTLE, PLASTIC (24470-944-02) | Plexion | Cintex Services, LLC | 2025-02-26 |
| 24470-0957-02 | 57 g in 1 BOTTLE, PLASTIC (24470-957-02) | SULFACETAMIDE SODIUM, SULFUR | Cintex Services, LLC | 2025-02-26 |
| 44118-0703-02 | 57 g in 1 BOTTLE, PLASTIC (44118-703-02) | Plexion | Eckson Labs LLC | 2022-03-30 |
| 44523-0600-02 | 1 BOTTLE, PLASTIC in 1 CARTON (44523-600-02) / 57 g in 1 BO... | SODIUM SULFACETAMIDE AND SULFUR | BioComp Pharma, Inc. | 2025-01-23 |
| 52187-0548-02 | 57 g in 1 BOTTLE, PLASTIC (52187-548-02) | SULFACETAMIDE SODIUM, SULFUR | KMM Pharmaceuticals, LLC | 2022-03-31 |
Observed labelers:
Cintex Services, LLC (2) ·
BioComp Pharma, Inc. (1) ·
Eckson Labs LLC (1) ·
KMM Pharmaceuticals, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.